SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CVS Health Corp. – ‘10-K’ for 12/31/22 – ‘EX-32.1’

On:  Wednesday, 2/8/23, at 6:37am ET   ·   For:  12/31/22   ·   Accession #:  64803-23-9   ·   File #:  1-01011

Previous ‘10-K’:  ‘10-K’ on 2/9/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 2/7/24 for 12/31/23   ·   46 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/08/23  CVS Health Corp.                  10-K       12/31/22  138:26M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   5.84M 
 2: EX-4.21     Instrument Defining the Rights of Security Holders  HTML     49K 
 3: EX-21.1     Subsidiaries List                                   HTML    191K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML     35K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     39K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     40K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     37K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     37K 
14: R1          Cover Page                                          HTML     99K 
15: R2          Audit Information                                   HTML     40K 
16: R3          Consolidated Statements of Operations               HTML    181K 
17: R4          Consolidated Statements of Comprehensive Income     HTML     75K 
18: R5          Consolidated Balance Sheets                         HTML    183K 
19: R6          Consolidated Balance Sheets (Parenthetical)         HTML     55K 
20: R7          Consolidated Statements of Cash Flows               HTML    152K 
21: R8          Consolidated Statements of Shareholders' Equity     HTML    112K 
22: R9          Consolidated Statements of Shareholders' Equity     HTML     81K 
                (Parentheticals)                                                 
23: R10         Consolidated Statements of Cash Flows               HTML     37K 
                (Parenthetical)                                                  
24: R11         Significant Accounting Policies                     HTML    295K 
25: R12         Acquisitions, Divestitures and Asset Sales          HTML     57K 
26: R13         Investments                                         HTML    329K 
27: R14         Fair Value                                          HTML    237K 
28: R15         Goodwill and Other Intangibles                      HTML     92K 
29: R16         Leases                                              HTML    184K 
30: R17         Health Care Costs Payable                           HTML     83K 
31: R18         Borrowings and Credit Agreements                    HTML    112K 
32: R19         Pension Plans and Other Postretirement Benefits     HTML    203K 
33: R20         Income Taxes                                        HTML    106K 
34: R21         Stock Incentive Plans                               HTML    111K 
35: R22         Shareholders' Equity                                HTML     61K 
36: R23         Other Comprehensive Income (Loss)                   HTML     81K 
37: R24         Earnings Per Share                                  HTML     58K 
38: R25         Reinsurance                                         HTML     66K 
39: R26         Commitments and Contingencies                       HTML     92K 
40: R27         Segment Reporting                                   HTML    130K 
41: R28         Significant Accounting Policies (Policies)          HTML    238K 
42: R29         Significant Accounting Policies (Tables)            HTML    194K 
43: R30         Acquisitions, Divestitures and Asset Sales          HTML     45K 
                (Tables)                                                         
44: R31         Investments (Tables)                                HTML    335K 
45: R32         Fair Value (Tables)                                 HTML    231K 
46: R33         Goodwill and Other Intangibles (Tables)             HTML     95K 
47: R34         Leases (Tables)                                     HTML    126K 
48: R35         Health Care Costs Payable (Tables)                  HTML     84K 
49: R36         Borrowings and Credit Agreements (Tables)           HTML    103K 
50: R37         Pension Plans and Other Postretirement Benefits     HTML    218K 
                (Tables)                                                         
51: R38         Income Taxes (Tables)                               HTML    107K 
52: R39         Stock Incentive Plans (Tables)                      HTML    113K 
53: R40         Shareholders' Equity (Tables)                       HTML     56K 
54: R41         Other Comprehensive Income (Tables)                 HTML     81K 
55: R42         Earnings Per Share (Tables)                         HTML     57K 
56: R43         Reinsurance (Tables)                                HTML     68K 
57: R44         Segment Reporting (Tables)                          HTML    128K 
58: R45         Significant Accounting Policies - Narrative         HTML    166K 
                (Details)                                                        
59: R46         Significant Accounting Policies - Cash and Cash     HTML     47K 
                Equivalents, Restricted Cash and Cash Equivalents                
                (Details)                                                        
60: R47         Significant Accounting Policies - Accounts          HTML     51K 
                Receivable (Details)                                             
61: R48         Significant Accounting Policies - Property and      HTML     55K 
                Equipment (Details)                                              
62: R49         Significant Accounting Policies - Disaggregation    HTML    103K 
                of Revenue (Details)                                             
63: R50         Significant Accounting Policies - Receivables and   HTML     40K 
                Contracted Balances (Details)                                    
64: R51         Significant Accounting Policies - Contract          HTML     42K 
                Balances (Details)                                               
65: R52         Significant Accounting Policies - Variable          HTML     58K 
                Interest Entities (Details)                                      
66: R53         Significant Accounting Policies - Discontinued      HTML     49K 
                Operations (Details)                                             
67: R54         Significant Accounting Policies - New Accounting    HTML     42K 
                Pronouncements Not Yet Adopted (Details)                         
68: R55         Acquisitions, Divestitures and Asset Sales -        HTML    100K 
                Narrative (Details)                                              
69: R56         Acquisitions, Divestitures and Asset Sales -        HTML     68K 
                Summary of Assets and Liabilities Held for Sale                  
                (Details)                                                        
70: R57         Investments - Schedule of Total Investments         HTML     51K 
                (Details)                                                        
71: R58         Investments - Narrative (Details)                   HTML     46K 
72: R59         Investments - Debt Securities (Details)             HTML     85K 
73: R60         Investments - Debt Securities by Maturity           HTML     79K 
                (Details)                                                        
74: R61         Investments - Unrealized Loss Position (Details)    HTML    112K 
75: R62         Investments - Unrealized Loss Position Maturities   HTML     98K 
                (Details)                                                        
76: R63         Investments - Mortgage Loans (Details)              HTML     42K 
77: R64         Investments - Mortgage Loans Credit Ratings         HTML     84K 
                Indicator (Details)                                              
78: R65         Investments - Mortgage Loan Principal Repayments    HTML     49K 
                (Details)                                                        
79: R66         Investments - Net Investment Income (Details)       HTML     59K 
80: R67         Investments - Realized Gains (Details)              HTML     42K 
81: R68         Fair Value - Fair Value Measurements (Details)      HTML    117K 
82: R69         Fair Value - Changes in Level 3 Financial Assets    HTML     91K 
                (Details)                                                        
83: R70         Fair Value - Gross Transfers Into (Out Of) Level 3  HTML     45K 
                (Details)                                                        
84: R71         Fair Value - Carrying Value and Fair Value          HTML     66K 
                Classified by Level (Details)                                    
85: R72         Fair Value - Separate Accounts Fair Value           HTML     77K 
                (Details)                                                        
86: R73         Fair Value - Narrative (Details)                    HTML     43K 
87: R74         Goodwill and Other Intangibles - Goodwill           HTML     59K 
                (Details)                                                        
88: R75         Goodwill and Other Intangibles - Narrative          HTML     48K 
                (Details)                                                        
89: R76         Goodwill and Other Intangibles - Intangible Assets  HTML     83K 
                (Details)                                                        
90: R77         Goodwill and Other Acquired Intangibles - Future    HTML     46K 
                Amortization Expense (Details)                                   
91: R78         Leases - Narrative (Details)                        HTML     78K 
92: R79         Leases - Summary of the Components of Net Lease     HTML     55K 
                Cost (Details)                                                   
93: R80         Leases - Supplemental Cash Flow Information         HTML     49K 
                (Details)                                                        
94: R81         Leases - Supplemental Balance Sheet Information     HTML     72K 
                (Details)                                                        
95: R82         Leases - Maturities of Operating and Finance Lease  HTML     97K 
                Liabilities (Details)                                            
96: R83         Health Care Costs Payable - Incurred and Paid       HTML     51K 
                Health Care Claims Development (Details)                         
97: R84         Health Care Costs Payable - Narrative (Details)     HTML     39K 
98: R85         Health Care Costs Payable - Liability for Unpaid    HTML     49K 
                Claims and Claims Adjustment Expense (Details)                   
99: R86         Health Care Costs Payable - Components of Change    HTML     76K 
                in Health Care Costs Payable (Details)                           
100: R87         Borrowings and Credit Agreements - Schedule of      HTML    199K  
                Borrowings (Details)                                             
101: R88         Borrowings and Credit Agreements - Debt Maturities  HTML     59K  
                (Details)                                                        
102: R89         Borrowings and Credit Agreements - Short-term       HTML     60K  
                Borrowings (Details)                                             
103: R90         Borrowings and Credit Agreements - Long-term        HTML    126K  
                Borrowings (Details)                                             
104: R91         Pension Plans and Other Postretirement Benefits -   HTML     67K  
                Narrative (Details)                                              
105: R92         Pension Plans and Other Postretirement Benefits -   HTML     84K  
                Benefit Obligations and Plan Assets (Details)                    
106: R93         Pension Plans and Other Postretirement Benefits -   HTML     52K  
                Net Periodic Benefit Cost (Income) (Details)                     
107: R94         Pension Plans and Other Postretirement Benefits -   HTML     44K  
                Weighted Average Assumptions Used (Details)                      
108: R95         Pension Plans and Other Postretirement Benefits -   HTML    164K  
                Fair Value of Pension Plan Assets (Details)                      
109: R96         Pension Plans and Other Postretirement Benefits -   HTML     54K  
                Changes in Level 3 Pension Plan Assets (Details)                 
110: R97         Pension Plans and Other Postretirement Benefits -   HTML     53K  
                Defined Benefit Plans Expected Benefit (Details)                 
111: R98         Income Taxes - Income Tax Provision (Details)       HTML     59K  
112: R99         Income Taxes - Effective Tax Rate Reconciliation    HTML     54K  
                (Details)                                                        
113: R100        Income Taxes - Deferred Tax Assets and Liabilities  HTML     81K  
                (Details)                                                        
114: R101        Income Taxes - Narrative (Details)                  HTML     46K  
115: R102        Income Taxes - Unrecognized Tax Benefits (Details)  HTML     49K  
116: R103        Stock Incentive Plans - Stock-Based Compensation    HTML     91K  
                Expense and ESPP (Details)                                       
117: R104        Stock Incentive Plans - Restricted Stock Activity   HTML     62K  
                (Details)                                                        
118: R105        Stock Incentive Plans - Stock Option and SAR        HTML    115K  
                Activity (Details)                                               
119: R106        Stock Incentive Plans - Valuation Assumptions       HTML     53K  
                (Details)                                                        
120: R107        Shareholders' Equity - Share Repurchases (Details)  HTML     51K  
121: R108        Shareholders' Equity - Accelerated Share            HTML     62K  
                Repurchases (Details)                                            
122: R109        Shareholders' Equity - Dividends (Details)          HTML     43K  
123: R110        Shareholders' Equity - Regulatory Requirements      HTML     50K  
                (Details)                                                        
124: R111        Shareholders' Equity - Noncontrolling Interests     HTML     40K  
                (Details)                                                        
125: R112        Other Comprehensive Income (Loss) (Details)         HTML     91K  
126: R113        Earnings Per Share (Details)                        HTML     86K  
127: R114        Reinsurance - Narrative (Details)                   HTML     39K  
128: R115        Reinsurance - Reinsurance Recoverables (Details)    HTML     49K  
129: R116        Reinsurance - Effects of Reinsurance (Details)      HTML     57K  
130: R117        Commitments and Contingencies (Details)             HTML     92K  
131: R118        Segment Reporting - Narrative (Details)             HTML     46K  
132: R119        Segment Reporting - Reconciliation of Financial     HTML     82K  
                Measures of Segments to Consolidated Totals                      
                (Details)                                                        
133: R120        Segment Reporting - Reconciliation from Operating   HTML     73K  
                Income to Adjusted Operating Income (Details)                    
136: XML         IDEA XML File -- Filing Summary                      XML    255K  
134: XML         XBRL Instance -- cvs-20221231_htm                    XML   7.85M  
135: EXCEL       IDEA Workbook of Financial Reports                  XLSX    366K  
10: EX-101.CAL  XBRL Calculations -- cvs-20221231_cal                XML    509K 
11: EX-101.DEF  XBRL Definitions -- cvs-20221231_def                 XML   1.74M 
12: EX-101.LAB  XBRL Labels -- cvs-20221231_lab                      XML   3.75M 
13: EX-101.PRE  XBRL Presentations -- cvs-20221231_pre               XML   2.37M 
 9: EX-101.SCH  XBRL Schema -- cvs-20221231                          XSD    369K 
137: JSON        XBRL Instance as JSON Data -- MetaLinks              926±  1.47M  
138: ZIP         XBRL Zipped Folder -- 0000064803-23-000009-xbrl      Zip   1.36M  


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 32.1
CERTIFICATION

The certification set forth below is being submitted in connection with the Annual Report of CVS Health Corporation (the "Company") on Form 10-K for the period ended December 31, 2022 (the “Report”) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.
I, Karen S. Lynch, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:February 8, 2023
/S/    KAREN S. LYNCH
Karen S. Lynch
President and Chief Executive Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/8/238-K
For Period end:12/31/224
 List all Filings 


12 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/08/24  CVS Health Corp.                  424B2                  2:528K                                   Donnelley … Solutions/FA
 5/07/24  CVS Health Corp.                  424B3                  1:490K                                   Donnelley … Solutions/FA
 8/02/23  CVS Health Corp.                  S-8         8/02/23    6:235K                                   Shearman & Sterling LLP
 6/01/23  CVS Health Corp.                  424B2                  2:536K                                   Donnelley … Solutions/FA
 5/30/23  CVS Health Corp.                  424B3                  1:507K                                   Donnelley … Solutions/FA
 5/25/23  CVS Health Corp.                  S-3ASR      5/25/23    7:437K                                   Shearman & Sterling LLP
 5/15/23  SEC                               UPLOAD6/13/23    2:39K  CVS Health Corp.
 5/11/23  SEC                               UPLOAD6/13/23    2:43K  CVS Health Corp.
 5/02/23  CVS Health Corp.                  S-8         5/02/23    5:247K                                   Shearman & Sterling LLP
 3/29/23  CVS Health Corp.                  S-8         3/29/23    5:195K                                   Shearman & Sterling LLP
 2/15/23  CVS Health Corp.                  424B2                  2:558K                                   Donnelley … Solutions/FA
 2/13/23  CVS Health Corp.                  424B3                  1:540K                                   Donnelley … Solutions/FA


34 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/21/22  CVS Health Corp.                  8-K:5,8,9  11/17/22   11:425K                                   Shearman & Sterling LLP
 9/06/22  CVS Health Corp.                  8-K:1,9     9/02/22   12:898K                                   Donnelley … Solutions/FA
 8/03/22  CVS Health Corp.                  10-Q        6/30/22   82:17M
 5/04/22  CVS Health Corp.                  10-Q        3/31/22   77:11M
 2/09/22  CVS Health Corp.                  10-K       12/31/21  137:25M
 8/18/21  CVS Health Corp.                  8-K:8,9     8/18/21   12:234K                                   Donnelley … Solutions/FA
 8/04/21  CVS Health Corp.                  10-Q        6/30/21   74:13M
 5/04/21  CVS Health Corp.                  10-Q        3/31/21   70:10M
 2/16/21  CVS Health Corp.                  10-K       12/31/20  137:25M
12/16/20  CVS Health Corp.                  8-K:8,9    12/16/20   13:293K                                   Donnelley … Solutions/FA
11/06/20  CVS Health Corp.                  10-Q        9/30/20   77:14M
 8/21/20  CVS Health Corp.                  8-K:8,9     8/21/20   14:446K                                   Donnelley … Solutions/FA
 5/19/20  CVS Health Corp.                  S-8         5/19/20    7:329K                                   Shearman & Sterling LLP
 3/31/20  CVS Health Corp.                  8-K:8,9     3/26/20   16:682K                                   Donnelley … Solutions/FA
 2/18/20  CVS Health Corp.                  10-K       12/31/19  147:29M
 8/15/19  CVS Health Corp.                  8-K:8,9     8/15/19   15:424K                                   Donnelley … Solutions/FA
 8/07/19  CVS Health Corp.                  10-Q        6/30/19   89:18M
 5/01/19  CVS Health Corp.                  10-Q        3/31/19   81:13M
 2/28/19  CVS Health Corp.                  10-K       12/31/18  142:25M
 6/05/18  CVS Health Corp.                  8-K:5,9     6/04/18    5:252K                                   Donnelley … Solutions/FA
 5/02/18  CVS Health Corp.                  10-Q        3/31/18   60:9M                                     Toppan Merrill Bridge/FA
 3/12/18  CVS Health Corp.                  8-K:8,9     3/06/18   12:771K                                   Donnelley … Solutions/FA
 8/08/17  CVS Health Corp.                  10-Q        6/30/17   57:8.8M                                   Toppan Merrill Bridge/FA
 2/09/17  CVS Health Corp.                  10-K       12/31/16  101:14M
 2/09/16  CVS Health Corp.                  10-K       12/31/15  102:14M
 5/01/15  CVS Health Corp.                  10-Q        3/31/15   47:3.9M
 2/10/15  CVS Health Corp.                  10-K       12/31/14   89:16M
 1/23/15  CVS Health Corp.                  8-K:5,9     1/20/15    2:58K
 2/11/14  CVS Health Corp.                  10-K       12/31/13   91:15M
 2/15/13  CVS Health Corp.                  10-K       12/31/12   87:14M                                    Toppan Merrill/FA
 8/04/09  CVS Health Corp.                  10-Q        6/30/09   29:2.2M                                   Donnelley … Solutions/FA
 2/27/09  CVS Health Corp.                  10-K       12/31/08   15:2M                                     Donnelley … Solutions/FA
 8/15/06  CVS Health Corp.                  8-K:1,9     8/10/06    3:428K                                   Davis Polk & … LLP 01/FA
11/04/96  CVS Health Corp.                  8-B12B                 4:39K                                    Davis Polk & … LLP 01/FA
Top
Filing Submission 0000064803-23-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 4:08:10.4am ET